b.next

About b.next

Provides an open-source synthetic cell platform, Nucleus, that enables the engineering of biological systems for research and application development. This platform addresses the challenges of building and manipulating cellular models by offering standardized tools and frameworks for creating synthetic cells, facilitating advancements in biotechnology and synthetic biology.

```xml <problem> Engineering biological systems for research and application development is currently hindered by the lack of standardized tools and frameworks for creating and manipulating cellular models. This makes it difficult to build and experiment with synthetic cells in a predictable and scalable manner. </problem> <solution> b.next offers Nucleus, an open-source synthetic cell platform designed to streamline the engineering of biological systems. Nucleus provides researchers with a standardized environment for building and manipulating synthetic cells, facilitating advancements in biotechnology and synthetic biology. The platform aims to simplify the creation of cellular models, enabling more efficient experimentation and development of novel applications. </solution> <features> - Open-source synthetic cell package - Standardized tools and frameworks for creating synthetic cells - Platform designed for engineering biological systems </features> <target_audience> The primary audience includes researchers, synthetic biologists, and biotechnology companies involved in engineering biological systems and developing novel applications using cellular models. </target_audience> ```

What does b.next do?

Provides an open-source synthetic cell platform, Nucleus, that enables the engineering of biological systems for research and application development. This platform addresses the challenges of building and manipulating cellular models by offering standardized tools and frameworks for creating synthetic cells, facilitating advancements in biotechnology and synthetic biology.

Where is b.next located?

b.next is based in Mountain View, United States.

When was b.next founded?

b.next was founded in 2023.

Who founded b.next?

b.next was founded by Akshay Maheshwari.

  • Akshay Maheshwari - CEO/Co-founder
Location
Mountain View, United States
Founded
2023
Employees
5 employees
Looking for specific startups?
Try our free semantic startup search

b.next

Score: 78/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Provides an open-source synthetic cell platform, Nucleus, that enables the engineering of biological systems for research and application development. This platform addresses the challenges of building and manipulating cellular models by offering standardized tools and frameworks for creating synthetic cells, facilitating advancements in biotechnology and synthetic biology.

bnext.bio700+
Founded 2023 – Mountain View, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (5+)

Akshay Maheshwari

CEO/Co-founder

Company Description

Problem

Engineering biological systems for research and application development is currently hindered by the lack of standardized tools and frameworks for creating and manipulating cellular models. This makes it difficult to build and experiment with synthetic cells in a predictable and scalable manner.

Solution

b.next offers Nucleus, an open-source synthetic cell platform designed to streamline the engineering of biological systems. Nucleus provides researchers with a standardized environment for building and manipulating synthetic cells, facilitating advancements in biotechnology and synthetic biology. The platform aims to simplify the creation of cellular models, enabling more efficient experimentation and development of novel applications.

Features

Open-source synthetic cell package

Standardized tools and frameworks for creating synthetic cells

Platform designed for engineering biological systems

Target Audience

The primary audience includes researchers, synthetic biologists, and biotechnology companies involved in engineering biological systems and developing novel applications using cellular models.